How to weigh enormous promise, potential danger of CRISPR/Cas9 technology

A technique for editing genes while they reside in intact chromosomes has been a real breakthrough. Literally. In 2013, Science magazine named it the runner-up for breakthrough-of-the-year, and its developers won the 2015 Breakthrough Prize.

The system being honored is called CRISPR/Cas9, and it evolved as a way for bacteria to destroy viruses using RNA that matched the virus’ DNA sequence. But it’s turned out to be remarkably flexible, and the technique can be retargeted to any gene simply by modifying the RNA. Researchers are still figuring out new uses for the system, which means there are papers coming out nearly every week, many of them difficult to distinguish.

That may be precisely why the significance of a paper published recently wasn’t immediately obvious. In it, the authors described a way of ensuring that if one copy of a gene was modified by CRISPR/Cas9, the second copy would be—useful, but not revolutionary. What may have been missed was that this process doesn’t stop once those two copies are modified. Instead, it happens in the next generation as well, and then the generation after that. In fact, the modified genes could spread throughout an entire species in a chain reaction, a fact that has raised ethical and safety concerns about the work.

Read full, original article: New DNA construct can set off a “mutagenic chain reaction”

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
_20250221_nib_rfk_trump
Viewpoint: 'Crisis of public trust': Autism support community shocked RFK continues to peddle false claims about the danger of vaccines
placebo
Viewpoint — Alternative medicine and the placebo effect: Selling a reassuring illusion of health
Screenshot-2026-05-19-at-11.23.34-AM
West-originated vaccine disinformation sparks murders of health care workers across Africa
ChatGPT-Image-May-18-2026-01_45_05-PM-2
Newest hantavirus conspiracy: Online disinformation turns outbreak into latest ivermectin grift
ChatGPT-Image-May-18-2026-12_06_18-PM-2
Defying death: The immortality movement goes mainstream
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.